CA-125 eqhelekileyo. Kuthetha ntoni ukwandisa?

Umhlaza Ovarian wokuqala singunobangela okhokhelela ekufeni ababhinqileyo ukusuka ngamathumba amabi. Idatha ezifunyenwe yi-Arhente International Lophando Umhlaza, icebisa ukuba ehlabathini lonke nyaka ngamnye, malunga 165 000 amatyala umhlaza ovarian kunye namabhinqa amatsha malunga 100,000 ababulawa kwesi sifo. ERashiya, 100 amawaka iimazi accounting ukuba amatyala 16 kunye nokufa-8 ezandleni yamathumba amabi ovarian. okulindeleke nale sifo ubuninzi emi-5, yaye kwezi, malunga ne-30% amatyala, njengokuba uninzi lwabafazi babhenele koogqirha uncedo kuphela zigaba yokugqibela sifo, xa uziva ugula kakhulu.

Uphuhliso iindlela ezisebenzayo une olu hlobo lomhlaza yi umsebenzi ongxamisekileyo. Okwangoku, kukho iindlela ezininzi ezahlukeneyo isigulo: ultrasound X-reyi Itomography kunye livakale Imagnethi, ngumzimba kunye ngokuhlahlela kwemichiza, laparoscopy. Eyona ziqhelekileyo kwaye esisetyenziswa ngokubanzi ukuqinisekisa ubukho umhlaza ovarian - glycoprotein iantigens CA-125, oko kukuthi oko yengundoqo oncomarker olu hlobo lomhlaza. CA-125 Normal igazi 35 U / ml.

A imali encinane CA-125 labafazi usoloko ekhona kule endometrium - le isifo zesibeleko. Ngenxa yobukho imiqobo zendalo, oko awukwazi ukungena kungena egazini. level CA-125 lidla ukuba banyukele 35 U / ml, kodwa kuphela xa esexesheni yaye ngokufuthi kunye endometriosis.

Izinga CA125 35 U / ml xa Isalathisi eliqingqiweyo engekho zizathu ngasentla, oko luphawu lomhlaza.

Oku kungaba somhlaza:
- isibeleko, tubes, zamaqanda
- lwebele
- ukukhanya
- pancreas
- wokugaya (colon, isibindi, isisu)
- ezinye ezinezigulo.

Iziqulatho CA-125 glycoprotein angandiswa kuphela kwimeko umhlaza uhlelo zokuzala ababhinqileyo, ngoko ukwenza uxilongo ngokusekelwe kuphela kwezi data, akunakwenzeka nokubi. izifundo oLongezelelweyo ezifunekayo kule meko. Oko kukuthi, uhlalutyo CA-125 isenokungabi isibonisi kuphela diagnostic.

Kwakhona izinga CA125 uvuke ngokwaneleyo ngamandla phambi yamathumba ingozi yempilo yamanina okanye izifo yokukrala ezihlobene. Kancinci anda ithumba njengommakishi iimeko zempilo zilandelayo:
• cysts ovarian
• Endometriosis
• Ukukrala kwe ezihlobene
• ndaba
• Peritonitis
• unepleurisy
• STIs (ezosulela ngokwabelana ngesondo ngu)
• kwesibindi, ukuqina
• i-pancreatitis ngendlela ezigulo ezondeleyo
• Kwakhona, kukho iimeko ezithile ukwanda kwi CA-125 ithumba ngummakishi izifo samathambo kwaye kwithuba leenyanga ezintathu yokuqala yokukhulelwa.

Blood Isalathisi Research CA-125 ikakhulu kusetyenziswa ukumisela umhlaza serous ovarian, nokuxilonga ukwenzeka kwayo. Phantse 83% ezigulane kunye ovarian umhlaza nabafazi umgangatho umxholo walo malunga 123-164 U / ml egazini. Kuba serous ovarian iifom umhlaza ukukhulisa imigangatho CA-125 kuxhomekeke eqongeni ithumba ngokwayo: inyathelo lokuqala nelesibini kukunyuka CA-125 nowama-50% amatyala, amanyathelo yesithathu neyesine sele kuzo zonke izigulane. Xa amabhinqa ovarian umhlaza ascites ifomu norm CA-125 egazini ligqithe -20 ukuya kuma-10 amawaka. U / ml.
Kunye nokususwa ngobuchule nethumba ukuya ichemotherapy okanye indicator intsumpa umxholo egazini CA-125 ucutho. Ukuba CA-125 banda ngakumbi, kuba sisalathisi ukuqhubela phambili somhlaza. Ngokuqhelekileyo, ukuvavanya ukusebenza kwinqanaba CA-125 ichemotherapy olufundwa njengoko phambi ikhosi nganye unyango kunye emva kokuba igqityiwe. Le periodicity na iinyanga 1-2.